I am quite sure MGC will follow the path of SAS if not takeover by another company.
Unless you really native enough to believe a "COVID-19 nature supplement" will be a "game-changer" and as Roby said "vital" to the business...
All my opinion of course, and I am glad to see my prediction is wrong though. But just have a look at BM's businesses, it seems not even single one is profitable
I am quite sure MGC will follow the path of SAS if not takeover...
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
0.010(1.89%) |
Mkt cap ! $26.13M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 57.0¢ | 54.0¢ | $66.55K | 120.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 334 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 1767 | 1 |
View Market Depth
| Last trade - 15.52pm 02/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |